Latest Breaking News On - Frontage laboratories - Page 10 : comparemela.com
Bioanalytical Testing Services Market Applications, Future Trends, Recent Demand, Growth Analysis, Insights, Types, Outlook, Size and Forecasts Report 2028
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Bioanalytical Testing Services Market Applications, Future Trends, Recent Demand, Growth Analysis, Insights, Types, Outlook, Size and Forecasts Report 2028
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Frontage Laboratories, Inc to Acquire Quintara Discovery, Inc
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Frontage Expands Genomics Services Through the Acquisition of Ocean Ridge Biosciences
News provided by
Share this article
Share this article
EXTON, Pa., April 19, 2021 /PRNewswire/ Frontage Laboratories, Inc. today announced the acquisition of Ocean Ridge Biosciences.
Ocean Ridge Biosciences, located in Deerfield Beach, Florida, provides genomic services to clients developing novel therapeutics, including complete service solutions for analysis of RNA expression, DNA polymorphisms, methylation, microbial composition, and protein biomarkers from a wide range of samples. The company s wet lab services are optimized for ultra-low input requirements and challenging sample types such as formalin-fixed paraffin-embedded tissues, skin swabs, and a variety of biofluids. Some of the core applications includes mechanism of action, lead optimization, biomarker discovery, and development of companion diagnostics.
Share this article
Share this article
EXTON, Pa., April 6, 2021 /PRNewswire/ Frontage Laboratories and Frontage Clinical Services are pleased to announce that we have developed the capability to perform full-service human Absorption, Metabolism, and Excretion (hAME) studies with radiolabeled compounds at our clinical site in Secaucus, NJ. We have obtained the full approval of the NJ Department of Environmental Protection to conduct such studies evaluating radiolabeled drug candidates in humans. Frontage Clinical Services, which has over 20 years of experience conducting early phase clinical research studies, plans to begin healthy volunteer recruitment and study conduct in Q2 2021.
The ability to execute in-life hAME studies at our 160-bed Phase 1 clinic in Secaucus, NJ complements Frontage s extensive experience in conducting radiolabeled studies, including Quantitative Whole-Body Autoradiography (QWBA)/dosimetry, mass balance, and metabolite identification/profiling.